Conscio Pharmaceuticals, Inc.

42 Summerfield Gardens
Shelton, CT 06484

Phone: 203-517-7406
Website: https://www.consciopharma.com/

Email: sean.isacsson@consciopharma.com

General Information:

Conscio Pharmaceuticals Inc. is a Shelton, CT based service organization providing pharmaceutical analytical services to the North American pharmaceutical marketplace. Conscio is an affiliate of Quinta Analytica of Czech Republic. Quinta is FDA and EU Authority inspected and operates under GMP, GLP and GCP certification. Quinta has been inspected by several multinational pharmaceutical companies.

Quinta is equipped with the state-of-the-art infrastructure, equipment and instrumentation. We are a customer centric organization and provide pharmaceutical analytical services in USA, Europe, Asia and Russia. No project is too big or small and each project is managed in a timely, cost effective and professional manner. Please visit our website and www.quinta.cz or the company LinkedIn page for more information on the company.

Conscio offers a wide array of pharmaceutical analytical services:

– Pharmaceutical Analysis
– Quality control, batch release analysis
– Validation and transfer of methods
– Stability studies
– Accelerated stability and degradation studies and
– Analysis of highly potent substances
– In-vitro studies including – Dissolution Apparatus 4
– Analyses of biologics
– Analytical research and development
– Determination of impurities and the characterization
– Analysis of inhalation products
– Synthesis and certification of reference materials

Clinical Testing
We specialize in pharmacokinetic studies on healthy volunteers according to the customer requirements. Clinical studies are conducted in a fully equipped facility with 60 hospital beds and their in-house experienced staff provide complete care and comfort to the study subjects.

Bioanalytical Testing 
Complete analytical services for clinical and pre-clinical studies, including statistical evaluation. Bioanalytical methods are developed and validated in accordance with GCP/GLP rules as well as ICH and FDA/EMA guidelines and to-date more than 300 methods have been developed and validated in the company including hormones and immunosuppressants.